<u>Stem cell </u>research has the potential to significantly impact the development of disease-modifying treatments for Parkinson’s disease with considerable progress made in creating dopamine-progressing cells.
Explanation:
Parkinson’s disease, a neurodegenerative disease, leads to reduction of dopamine (a neurochemical messenger which carries messages involving thinking and body movements to brain) in the body because the disease will target and kill dopamine-producing nerve cells (neurons). This leads to loss of movement and thinking abilities which are activated by dopamine.
Stem cells research is done to study about the prospects of stem cells in stem cell therapy for Parkinson’s patients as a viable source of new dopamine nerve cells. Research has been involved in growing stem cells to replace or regenerate dopamine-producing nerve cells by using embryonic stem cells or induced pluripotent stem cells as a treatment modality in Parkinson’s disease.
It causes anemia thrombocytopenia and decreased neutrophil function. Anemia is caused by decreased erythropoitin
Answer:
results will be more accurate if there is a larger sample size.
No matter what research is, the larger sample size is, the more accurately will be the results and vice versa. The larger samples increase a chance of significance because they reflect the population mean more reliably.
With small sample, the chance for false conclusions is higher.
Explanation:
These ions bind to troponin, which forms a complex with tropomyosin. The process is called <span>Excitation-Contraction Coupling 3.</span>
It includes series of events, beginning with the production of an electrical impulse (action potential)<span> and ending with </span>contraction<span> of </span>muscles <span>in the </span>heart.
